Core Viewpoint - Bluefan Medical's stock closed at 4.49 yuan, down 2.39%, with a latest price-to-book ratio of 0.52 and a total market capitalization of 4.522 billion yuan [1] Company Overview - Bluefan Medical Co., Ltd. primarily operates in cardiovascular, health protection, and nursing businesses, with key products including coronary intervention devices, structural heart disease products, health protection gloves, and emergency rescue products [1] - The company is a global leader in the PVC health protection gloves industry, holding the highest annual production and market share [1] Shareholder Information - As of March 31, 2025, Bluefan Medical had 81,034 shareholders, a decrease of 1,123 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Financial Performance - In the latest quarterly report for Q3 2024, the company achieved a revenue of 4.654 billion yuan, representing a year-on-year increase of 29.85%, while the net profit was -219.82 million yuan, a year-on-year decline of 38.19%, with a gross profit margin of 17.17% [1] Valuation Metrics - Bluefan Medical's PE (TTM) is -10.45, PE (static) is -7.96, and the price-to-book ratio is 0.52, with a total market value of 4.522 billion yuan [2]

4月14日，蓝帆医疗今日收盘4.68元，上涨2.63%，最新市净率0.55，总市值47.13亿元。 资金流向方面，4月14日，蓝帆医疗主力资金净流出239.68万元，近5日总体呈流出状态，5日共流出 2073.07万元。 来源：金融界 蓝帆医疗股份有限公司主要业务是心脑血管业务、健康防护业务及护理业务。公司主要产品包括冠脉植 介入、结构性心脏病以及和心脏介入手术相关的医疗器械产品，健康防护手套，以急救箱包为主的各类 紧急救援产品和一次性健康防护用品。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防 护手套年产销量及市场占有率均为全球第一。 最新一期业绩显示，2024年三季报，公司实现营业收入46.54亿元，同比29.85%；净利润-219822842.84 元，同比38.19%，销售毛利率17.17%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)23蓝帆医疗-10.90-8.290.5547.13亿行业平均 45.7149.434.75102.82亿行业中值29.9929.792.3746.97亿1硕世生物-1863.40-1863.401.1738.50亿2诺唯 赞-532.18-5 ...